Distinct mutation profiles between primary bladder cancer and circulating tumor cells warrant the use of circulating tumors cells as cellular resource for mutation follow-up
Tae‐Min Kim(Catholic Medical Center), U‐Syn Ha(St. Mary's Hospital)
Cited by 8
Related Papers
Subclonal Genomic Architectures of Primary and Metastatic Colorectal Cancer Based on Intratumoral Genetic Heterogeneity
|Clinical Cancer Research|2015|164
Genomic differences between pure ductal carcinoma <i>in situ</i> and synchronous ductal carcinoma <i>in situ</i> with invasive breast cancer
|Oncotarget|2015|88